Bernadine Angeles
SubscribersAbout
Diets that are too low in fat (below 15–20% of total calories) may reduce testosterone levels. However, some individuals adapt well to low-carb diets and can still gain muscle if they maintain a calorie surplus and adequate protein intake. Low-carb diets often reduce glycogen stores, which can lead to decreased strength, endurance, and training volume. Most research in muscle growth science suggests consuming around 3–6 grams of carbs per kilogram of body weight per day. Carbs fuel your muscles through glycogen, allowing you to lift heavier and train harder, which directly supports hypertrophy.
The results were similar for professional English soccer players who ingested an average of 4.2–6.4 g/kg BW/day during match and training days, respectively.5 This apparent gap between actual carbohydrate intake and current recommendations may not be as worrisome as it may seem because, as discussed later in this review, even a carbohydrate intake of The vastus lateralis muscle of the quadriceps muscle group on the front of the thigh is a common site for muscle biopsies because that particular muscle is active during running and cycling, exercise modalities often used in laboratory studies. Intramyofibrillar glycogen is used by the sarcoplasmic reticulum to allow for calcium release and muscle contraction, so its depletion likely contributes to fatigue.51,52
Cortisol is also involved in adaptations to exercise by preparing the body for the next bout of exercise (71, 174), as increases in cortisol are prolonged before returning to basal levels following a bout of exercise. The acute cortisol response to exercise is highest when the overall stress (volume and/or intensity of total work) of the training period is high (145, 173). In the periphery, the cellular response to glucocorticoids differs by cell type (167–169), cell cycle stage (167), and exposure to stress (170). This leads to the activation of downstream signaling pathways of IGFs including PI 3-kinase pathway and Ras-mitogen-activated protein kinase (MAP kinase) pathway, for cell proliferation, cell differentiation and cell survival (160). Resistance exercise training of sufficient intensity and volume increases IGF-I and MGF mRNA for up to 48 h post RE (21, 157). Long term resistance exercise training studies examining resting circulating IGF-I concentrations have been demonstrated to be highly variable with reductions, no change, and elevations with no change or reductions in IGFBP-1 and IGFBP-3 (21). However, IGFBP-2 increased and ALS decreased indicating that binding protein partitioning, rather than changes in systemic IGF-I, appeared to be an important finding.
In comparison, an endurance athlete who trains for hours at a time will also experience a marked decline in muscle glycogen, although at a slower rate of degradation than the sprinter. Circadian patterning and newly discovered variants of glucocorticoid isoforms largely dictate glucocorticoid sensitivity and catabolic, muscle sparing, or pathological influence. The actions of IGF-I are regulated by a family of binding proteins (IGFBPs 1–6), which can either stimulate or inhibit biological action depending on binding. Glucocorticoid exposure (237), acute endurance exercise (234), and hyperglycemia lead to increased KLF15 expression.
(a) availability of the recombinant product and (b) closure of the National Pituitary Agency (in 1985) for production of hGH extracted from human pituitary glands, led to overwhelming use of antibody- based technology (e.g., polyclonal, monoclonal antibodies) and less frequently used cell- based bioassays for GH measurements. This form was active in the tibial bioassay as well as other bioassays having the growth endpoint. Moreover, the relative concentrations of bioactive GH in the rat pituitary and/or circulation (including human plasma) changed differentially in response to a variety of physiological stimuli (e.g., cold stress, fasting, insulin injection). During this transition period, a critically important experimental series by Ellis et al. (95) was designed to compare results generated between rat growth assays and GH immunoassays. To the best of our knowledge, it was also during this time period (1965) that the first study documenting that human exercise was a potent stimulus for the release of GH from the pituitary appeared (94).
In an attempt to better understand the discrepancies between testosterone and muscle adaptive responses, Phillips and colleagues devised a unique experimental approach, whereby they compared a "high" vs. "low" hormone environment (induced by working distinct muscle bulk) (West et al., 2010). It therefore may be that the combined effects of acute testosterone elevation post exercise and sustained AR upregulation in the muscle may represent an additional mechanism through which RE might regulate muscle growth. Further, early increased circulating testosterone levels during RE are also LH-independent and it seems they may be directly stimulated via increases in lactate levels induced by an increase in the production of cAMP in testicular tissues (Lin et al., 2001). It seems high intensity RE stimulates basophilic cells of the anterior pituitary to release luteinizing hormone (LH) from gonadotrophs in the anterior pituitary which then acts as the primary regulator of testosterone secretion from the Leydig cells of the testes (Fry and Kraemer, 1997). For example, immediately following RE, serum testosterone levels peak ~from 13 (resting levels) to 38 (at ~30 mins) nmol.L−1 with a concomitant upregulation of AR mRNA and protein content within the muscle (Willoughby and Taylor, 2004; Hooper et al., 2017). Together, these findings suggest a significant role for testosterone in regulating adult muscle growth in response to mechanical loading (i.e., RE).
Free (unbound, up to 2% in circulation) T (FT) is taken up by tissues for binding to membrane-bound or cytoplasmic ARs and subsequent cellular signaling. Testosterone is released into circulation and transported mostly by sex hormone-binding globulin (SHBG) (44–60%) and loosely-bound to albumin or other proteins. Genomic androgen/AR binding may alter the expression of more than 90 genes, several of which are involved in the regulation of skeletal muscle structure, fiber types, metabolism, and transcription (6). Testosterone performs a multitude of ergogenic, anabolic, and anti-catabolic functions in skeletal muscle and neuronal tissue leading to increased muscle strength, power, endurance, and hypertrophy in a dose-dependent manner (1). All stages from production, release, transportation, tissue uptake, and intracellular signaling must be considered in an integrative manner to accurately portray the effects of the hormone-receptor interaction (1). Cell signaling may be described as a critical part of communication that governs basic activities of cells and coordinates all cellular actions. Again, this may be related to creatine's promotion of glycogen in muscle, because glucose-derived energy is needed to help the healing process.
Glucocorticoid response elements regulate the transcription of primary target genes by either directly binding to DNA (185), tethering onto other DNA-binding transcription factors (185), or through direct protein-protein interactions with other transcription factors and/or coregulators (186). In the cytoplasm, the glucocorticoid receptor is found in a complex with chaperone proteins that maintain a conformation with high affinity binding potential (89). Raised expression of 11β-HSD1 (Type 1) in skeletal muscle is believed to play role in mechanisms that contribute to the development of metabolic syndrome (180) insulin resistance (181), and hypertension (182). Inactivation of cortisol into cortisone acts as another mechanism to protect tissues and cells from the deleterious effects of exercise-related cortisol secretion (175).
Dietary fats play an important role in hormone production, including testosterone, which is linked to muscle growth. Fats, on the other hand, play a crucial role in hormone production, including testosterone, which indirectly supports muscle growth. In both types of muscle of the hyperglycaemic testosterone treated exercised subgroup, less depletion of glycogen was found than in the untreated group (38% and 87% for EDL and soleus respectively). PIP3 is then free to bind to phosphoinositide-dependent kinase-1 (PDK1) which activates the Akt-mTORC1 pathway (Schiaffino and Mammucari, 2011) promoting ribosomal biogenesis and translation to permit increases in MPS and the formation myofibrillar proteins, which allows muscle mass growth (Menon et al., 2014; Wen et al., 2016) (Figure 1). If such a sequestration of IGF-1 into muscle increases during RE (with a decrease in cellular GH receptors), it might occur as a result of reduced GH-induced hepatic production (Eliakim et al., 1998) and it may be speculated that the effect would be more pronounced in individuals experiencing greater activation of intracellular muscle signaling and subsequent muscle hypertrophy and performance (Velloso, 2008; Arnarson et al., 2015; Morton et al., 2016). Therefore, serum levels of IGF-1 (resting levels or acutely after RE) may not be a good reflection of local effects of IGF-1 (Bartke and Darcy, 2017; Van Nieuwpoort et al., 2018), especially in those tissues that have capabilities of producing the hormone themselves, such as skeletal muscle (Barclay et al., 2019). Bikle et al. also showed muscle atrophy was more pronounced after ablation of muscle IGF-1 production than when hepatic IGF-1 production was suppressed (Bikle et al., 2015); exhibiting circulating levels of IGF-1 (i.e., endocrine factor) do not effect overall growth responses (Ohlsson et al., 2000; Velloso, 2008).
The results were similar for professional English soccer players who ingested an average of 4.2–6.4 g/kg BW/day during match and training days, respectively.5 This apparent gap between actual carbohydrate intake and current recommendations may not be as worrisome as it may seem because, as discussed later in this review, even a carbohydrate intake of The vastus lateralis muscle of the quadriceps muscle group on the front of the thigh is a common site for muscle biopsies because that particular muscle is active during running and cycling, exercise modalities often used in laboratory studies. Intramyofibrillar glycogen is used by the sarcoplasmic reticulum to allow for calcium release and muscle contraction, so its depletion likely contributes to fatigue.51,52
Cortisol is also involved in adaptations to exercise by preparing the body for the next bout of exercise (71, 174), as increases in cortisol are prolonged before returning to basal levels following a bout of exercise. The acute cortisol response to exercise is highest when the overall stress (volume and/or intensity of total work) of the training period is high (145, 173). In the periphery, the cellular response to glucocorticoids differs by cell type (167–169), cell cycle stage (167), and exposure to stress (170). This leads to the activation of downstream signaling pathways of IGFs including PI 3-kinase pathway and Ras-mitogen-activated protein kinase (MAP kinase) pathway, for cell proliferation, cell differentiation and cell survival (160). Resistance exercise training of sufficient intensity and volume increases IGF-I and MGF mRNA for up to 48 h post RE (21, 157). Long term resistance exercise training studies examining resting circulating IGF-I concentrations have been demonstrated to be highly variable with reductions, no change, and elevations with no change or reductions in IGFBP-1 and IGFBP-3 (21). However, IGFBP-2 increased and ALS decreased indicating that binding protein partitioning, rather than changes in systemic IGF-I, appeared to be an important finding.
In comparison, an endurance athlete who trains for hours at a time will also experience a marked decline in muscle glycogen, although at a slower rate of degradation than the sprinter. Circadian patterning and newly discovered variants of glucocorticoid isoforms largely dictate glucocorticoid sensitivity and catabolic, muscle sparing, or pathological influence. The actions of IGF-I are regulated by a family of binding proteins (IGFBPs 1–6), which can either stimulate or inhibit biological action depending on binding. Glucocorticoid exposure (237), acute endurance exercise (234), and hyperglycemia lead to increased KLF15 expression.
(a) availability of the recombinant product and (b) closure of the National Pituitary Agency (in 1985) for production of hGH extracted from human pituitary glands, led to overwhelming use of antibody- based technology (e.g., polyclonal, monoclonal antibodies) and less frequently used cell- based bioassays for GH measurements. This form was active in the tibial bioassay as well as other bioassays having the growth endpoint. Moreover, the relative concentrations of bioactive GH in the rat pituitary and/or circulation (including human plasma) changed differentially in response to a variety of physiological stimuli (e.g., cold stress, fasting, insulin injection). During this transition period, a critically important experimental series by Ellis et al. (95) was designed to compare results generated between rat growth assays and GH immunoassays. To the best of our knowledge, it was also during this time period (1965) that the first study documenting that human exercise was a potent stimulus for the release of GH from the pituitary appeared (94).
In an attempt to better understand the discrepancies between testosterone and muscle adaptive responses, Phillips and colleagues devised a unique experimental approach, whereby they compared a "high" vs. "low" hormone environment (induced by working distinct muscle bulk) (West et al., 2010). It therefore may be that the combined effects of acute testosterone elevation post exercise and sustained AR upregulation in the muscle may represent an additional mechanism through which RE might regulate muscle growth. Further, early increased circulating testosterone levels during RE are also LH-independent and it seems they may be directly stimulated via increases in lactate levels induced by an increase in the production of cAMP in testicular tissues (Lin et al., 2001). It seems high intensity RE stimulates basophilic cells of the anterior pituitary to release luteinizing hormone (LH) from gonadotrophs in the anterior pituitary which then acts as the primary regulator of testosterone secretion from the Leydig cells of the testes (Fry and Kraemer, 1997). For example, immediately following RE, serum testosterone levels peak ~from 13 (resting levels) to 38 (at ~30 mins) nmol.L−1 with a concomitant upregulation of AR mRNA and protein content within the muscle (Willoughby and Taylor, 2004; Hooper et al., 2017). Together, these findings suggest a significant role for testosterone in regulating adult muscle growth in response to mechanical loading (i.e., RE).
Free (unbound, up to 2% in circulation) T (FT) is taken up by tissues for binding to membrane-bound or cytoplasmic ARs and subsequent cellular signaling. Testosterone is released into circulation and transported mostly by sex hormone-binding globulin (SHBG) (44–60%) and loosely-bound to albumin or other proteins. Genomic androgen/AR binding may alter the expression of more than 90 genes, several of which are involved in the regulation of skeletal muscle structure, fiber types, metabolism, and transcription (6). Testosterone performs a multitude of ergogenic, anabolic, and anti-catabolic functions in skeletal muscle and neuronal tissue leading to increased muscle strength, power, endurance, and hypertrophy in a dose-dependent manner (1). All stages from production, release, transportation, tissue uptake, and intracellular signaling must be considered in an integrative manner to accurately portray the effects of the hormone-receptor interaction (1). Cell signaling may be described as a critical part of communication that governs basic activities of cells and coordinates all cellular actions. Again, this may be related to creatine's promotion of glycogen in muscle, because glucose-derived energy is needed to help the healing process.
Glucocorticoid response elements regulate the transcription of primary target genes by either directly binding to DNA (185), tethering onto other DNA-binding transcription factors (185), or through direct protein-protein interactions with other transcription factors and/or coregulators (186). In the cytoplasm, the glucocorticoid receptor is found in a complex with chaperone proteins that maintain a conformation with high affinity binding potential (89). Raised expression of 11β-HSD1 (Type 1) in skeletal muscle is believed to play role in mechanisms that contribute to the development of metabolic syndrome (180) insulin resistance (181), and hypertension (182). Inactivation of cortisol into cortisone acts as another mechanism to protect tissues and cells from the deleterious effects of exercise-related cortisol secretion (175).
Dietary fats play an important role in hormone production, including testosterone, which is linked to muscle growth. Fats, on the other hand, play a crucial role in hormone production, including testosterone, which indirectly supports muscle growth. In both types of muscle of the hyperglycaemic testosterone treated exercised subgroup, less depletion of glycogen was found than in the untreated group (38% and 87% for EDL and soleus respectively). PIP3 is then free to bind to phosphoinositide-dependent kinase-1 (PDK1) which activates the Akt-mTORC1 pathway (Schiaffino and Mammucari, 2011) promoting ribosomal biogenesis and translation to permit increases in MPS and the formation myofibrillar proteins, which allows muscle mass growth (Menon et al., 2014; Wen et al., 2016) (Figure 1). If such a sequestration of IGF-1 into muscle increases during RE (with a decrease in cellular GH receptors), it might occur as a result of reduced GH-induced hepatic production (Eliakim et al., 1998) and it may be speculated that the effect would be more pronounced in individuals experiencing greater activation of intracellular muscle signaling and subsequent muscle hypertrophy and performance (Velloso, 2008; Arnarson et al., 2015; Morton et al., 2016). Therefore, serum levels of IGF-1 (resting levels or acutely after RE) may not be a good reflection of local effects of IGF-1 (Bartke and Darcy, 2017; Van Nieuwpoort et al., 2018), especially in those tissues that have capabilities of producing the hormone themselves, such as skeletal muscle (Barclay et al., 2019). Bikle et al. also showed muscle atrophy was more pronounced after ablation of muscle IGF-1 production than when hepatic IGF-1 production was suppressed (Bikle et al., 2015); exhibiting circulating levels of IGF-1 (i.e., endocrine factor) do not effect overall growth responses (Ohlsson et al., 2000; Velloso, 2008).
